UBS’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$983K Buy
15,582
+3,435
+28% +$196K ﹤0.01% 3612
2014
Q2
$642K Sell
12,147
-17,516
-59% -$878K ﹤0.01% 3981
2014
Q1
$1.6M Buy
29,663
+3,014
+11% +$154K ﹤0.01% 3000
2013
Q4
$1.2M Buy
26,649
+6,871
+35% +$314K ﹤0.01% 3330
2013
Q3
$993K Buy
19,778
+2,529
+15% +$124K ﹤0.01% 3343
2013
Q2
$793K Buy
+17,249
New +$758K ﹤0.01% 3593

Other funds holding PRXL

UBS's PRXL Position: Q3 2014 in Review

UBS increased its Parexel International Corp (PRXL) stake by 28% in Q3 2014, buying an estimated $196K and bringing the position to 15,582 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

UBS first reported a position in PRXL in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.6M in Q1 2014. 271 funds tracked by Wall St. Rank hold PRXL as of Q3 2014.

  • UBS held 15,582 shares of Parexel International Corp worth $983K as of Q3 2014.
  • UBS bought 3,435 Parexel International Corp shares in Q3 2014, an estimated $196K.
  • Parexel International Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3612 holding.
  • UBS first reported a position in Parexel International Corp in Q2 2013 and has held it in 6 quarters since.
  • UBS's Parexel International Corp position peaked at $1.6M in Q1 2014.
  • 271 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.